Skip to main content
SpringerLink
Log in

Severe Hypoglycemia in Adults

  • Published:
Reviews in Endocrine and Metabolic Disorders Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Boyle PJ, Schwartz NS, Shah SD, Clutter WE, Cryer PE. Plasma glucose concentration at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in non-diabetics. N Engl J Med 1988;318:1487–1492.

    Google Scholar 

  2. Merimee TJ, Tyson JE. Stabilization of plasma glucose during fasting. Normal variation in two separate studies. N Engl J Med 1974;291:1275–1278.

    Google Scholar 

  3. Brunner GA, Ellmerer M, Sendlhofer G, Wutte A, Trajanoski Z, Schaupp L, Quehenberger F, Wach P, Krejs G, Peiber TR. Validation of home blood glucose meters with respect to clinical and analytical approaches. Diabetes Care 1998;21:585–590.

    Google Scholar 

  4. Jungheim K, Koschinsky T. Risky delay of hypoglycemia detection by glucose monitoring at the arm. Diabetes Care 2001;24:1303–1306.

    Google Scholar 

  5. Tamada JA, Garg SK, Jovanovic L, Pitzer KR, Fermi S, Potts RO. Non-invasive glucose monitoring: comprehensive clinical results. JAMA 1999;282:1839–1844.

    Google Scholar 

  6. Garg SK, Potts RO, Ackerman NR, Fermi SJ, Tamada JA, Chase HP. Correlation of Fingerstick blood glucose measurements with Glucowatch Biographer glucose results in young subjects with type 1 diabetes Diabetes Care 1999;22:1708–1714.

    Google Scholar 

  7. Hart SP, Frier BM. Causes, management and morbidity of acute hypoglycemia in adults requiring hospital admission. Q J Med 1998;91:505–510.

    Google Scholar 

  8. Huic M, Mucolic V, Vrhovac B, Francetic I, Bakran I, Gilanovic S. Adverse drug reactions resulting in hospital admission. Int J Clin Pharmacol Ther 1994;32:675–682.

    Google Scholar 

  9. Klatt EC, Beatie C, Noguchi TT. Evaluation of death from hypoglycemia. Am J Forensic Med Pathol 1988;122–125.

  10. The Diabetes Control and Complications Trial research group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997;46:271–286.

    Google Scholar 

  11. The UKPDS Research Group: Overviewof 6 years of therapy of type II diabetes: A progressive disease. Diabetes 1995;44:1249–1258.

    Google Scholar 

  12. Hepburn DA, MacLeod KM, Pell AC, Scougal IJ, Frier BM. Frequency and symptoms of hypoglycemia experienced by patients with type 2 diabetes treated with insulin. Diabetic Med 1993;10:231–237.

    Google Scholar 

  13. Wahren J, Ekberg K, Fernquist-Forbes E, Nair S. Brain substrate utilisation during acute hypoglycemia. Diabetologia 1999;42:812–818.

    Google Scholar 

  14. Gerich JE, Cryer P, Rizza RA. Hormonal mechanisms in acute glucose counterregulation: The relative roles of glucagon, epinephrine, norepinephrine, growth hormone and cortisol. Metabolism 1980; 29:1165.

    Google Scholar 

  15. Boyle PJ, Kempers SF, O'Connor AM, Nagy RJ. Brain glucose uptake and unawareness of hypoglycemia in patients with insulindependent diabetes mellitus. N Engl J Med 1995;333:1726–1731.

    Google Scholar 

  16. Davis M, Mellman M, Friedman S, Chang CJ, Shamoon H. Recovery of epinephrine response but not hypoglycemic symptoms threshold after intensive insulin therapy in type 1 diabetes. Am J Med 1994;97:535–542.

    Google Scholar 

  17. Burge MR, Sobhy TA, Qualls CR, Schade DS. Effect of short-term glucose control on glycemic thresholds for epinephrine and hypoglycemic symptoms. J Cin Endocrinol Metab 2001;86:5471–5478.

    Google Scholar 

  18. Burge MR, Schmitz-Fiorentino, Fischette C, Qualls CR, Schade DS. A prospective trial of risk factors for sulfonlyurea-induced hypoglycemia in type 2 diabetes mellitus. JAMA 1998;279:137–143.

    Google Scholar 

  19. Service FJ. Classification of hypoglycemic disorders. Endocrinology and Metabolism Clinics of North America 1999;28:501–517.

    Google Scholar 

  20. Allen C, LeCaire T, Palta M, Daniels K, Meredith M, D'Alessio DJ. Risk factors for frequent and severe hypoglycemia in type 1 diabetes. Diabetes Care 2001;24:1878–1881.

    Google Scholar 

  21. Bott S, Bott U, Berger M, Mulhauser I. Intensified insulin therapy and the risk of severe hypoglycemia. Diabetologia 1997;40:926–932.

    Google Scholar 

  22. Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type 1 diabetes. Lancet 1993;341:1306–1309.

    Google Scholar 

  23. Airey CM, Williams DR, Martin PG, Bennett CM, Spoor PA. Hypoglycemia induced by exogenous insulin-‘human’ and animal insulin compared. Diabet Med 2000;17:416–432.

    Google Scholar 

  24. Yki-Jarvinen H, Dressler A, Ziemen M. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. Diabetes Care 2000;23(8):1130–1136.

    Google Scholar 

  25. Ferguson SC, Strachan MW, Janes JM, Frier BM. Severe hypoglycemia in patients with type 1 diabetes and impaired awareness of hypoglycemia: A comparative study of insulin lispro and regular human insulin Diabetes Metab Res Rev 2001;17:285–291.

    Google Scholar 

  26. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane W. Continuous subcutaneous insulin infusion. Diabetes Care 1999;22:1779–1784.

    Google Scholar 

  27. Litovitz TL, Klein-Schwartz W, White S, Cobaugh DJ, Youniss J, Drab A, Benson BE. 1999 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2000;18:517–574.

    Google Scholar 

  28. Stahl M, Berger W. Higher incidence of severe hypoglycemia leading to hospital admission in type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas. Diabet Med 1999;586–590.

  29. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas. JAMA 1997;278:40–43.

    Google Scholar 

  30. Ciechanowski K, Borowiak KS, Potocka BA, Nowacka M, Dutkiewicz G. Chlorpropamide toxicity with survival despite 27-day hypoglycemia. J Toxicol Clin Toxicol 1999;37:869–871.

    Google Scholar 

  31. Klonoff DC, Barrett BJ, Nolte MS, Cohen RM, Wyderski R. Hypoglycemia following inadvertent and factitious sulfonylurea overdoses. Diabetes Care 1995;18:563–567.

    Google Scholar 

  32. Campbell RK. Glimepiride: role of new sulfonylureas in the treatment of type 2 diabetes mellitus. Ann Pharmacother 1998;32:1044–1052.

    Google Scholar 

  33. Landgraf R, Bilo HG, Muller PG. A comparison of repaglinide and glibenclamide in the treatment of type 2 diabetic patients previously treated with sulphonylureas. Eur J Clin Pharmacol 1999;55:165–171.

    Google Scholar 

  34. Carroll MF, Riboni K, Izard A, Burge MR, Schade DS. Acute Glucose-lowering effects of Pre-meal Nateglinide versus Glipizide in Type 2 Diabetes. Diabetes 2002;25:2147–2152.

    Google Scholar 

  35. Wilson NM, Brown PM, Juul SM, Prestwich SA, Sonksen PH. Glucose turnover and metabolic and hormonal changes in ethanolinduced hypoglycemia. Br Med J 1981;282:849–853.

    Google Scholar 

  36. Sood V, Sobhy T, Schade DS, Burge MR. Low dose ethanol alters epinephrine responses and decreases glucose production during hypoglycemia in patients with type 2 diabetes. Diabetes 2001;50(Suppl. 1):A139.

    Google Scholar 

  37. Marks V, Teale JD. Drug-induced hypoglycemia. Endocrinology and Metabolism Clinics of North America 1999;28:555–577.

    Google Scholar 

  38. Sporer KA, Ernst A, Conte R. The incidence of ethanol-induced hypoglycemia. Am J Emerg Med 1992;10:403–405.

    Google Scholar 

  39. Service FJ. Diagnostic approach to adults with hypoglycemic disorders. Endocrinology and Metabolism Clinics of North America 1999;28:519–532.

    Google Scholar 

  40. Service FJ, Natt N, Thompson GB, Grant CS, van Heerden JA, Andrews JC, Lorenz E, Terzic A, Lloyd RV. Noninsulinoma pancreatogenous hypoglycemia: A novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kirb.2 and SUR1 genes. J Clin Endocrinol Metab 1999;84:1582–1589.

    Google Scholar 

  41. Matyka K, Evans M, Lomas J, Cranston I, Macdonaldl I, Amiel SA. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 1997;20:135–141.

    Google Scholar 

  42. McCrimmon RJ, Frier BM. Symptomatic and physiologic responses to hypoglycemia induced by human soluble insulin and the analogue lispro human insulin. Diabet Med 1997;14:929–936.

    Google Scholar 

  43. Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type 1 diabetes with impaired awareness of hypoglycemia. Diabetes Care 1994;17:697–703.

    Google Scholar 

  44. Fritsche AF, Stefan N, Haring H, Gerich J, Stumvoll M. Avoidance of hypoglycemia restores hypoglycemia awareness by increasing β-adrenergic sensitivity in type 1 diabetes. Ann Intern Med 2001;134:729–736.

    Google Scholar 

  45. Cranston I, Lomas J, Maran A, Macdonald I. Amiel SA. Restoration of hypoglycemia unawareness in patients with long-duration insulindependent diabetes mellitus. Lancet 1994;344:283–287.

    Google Scholar 

  46. Mitrakou A, Fanelli C, Veneman T, Perriello G, Calderone S, Platanisiotis D, Rambotti A, Raptis S, Brunetti P, Cryer P. Reversibility of hypoglycemia unawareness in patients with insulinomas. N Engl J Med 1993;329:834–839.

    Google Scholar 

  47. Collier PA, Steedman DJ, Patrick AW, Nimbo GR, Matthews DM, McIntyre CC, Little K, Clarke BF. Comparison of intravenous glucagon and dextrose in treatment of severe hypoglycemia in an accident and emergency department. Diabetes Care 1987;10:712–715.

    Google Scholar 

  48. Boyle PJ, Justice K, Krentz AJ, Nagy RJ. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses. J Clin Endocrinol Metab 1993;76:752–756.

    Google Scholar 

  49. Pramming S, Thosteinsson B, Bendtson I, Binder C. Symptomatic hypoglycemia in 411 type 1 diabetes patients. Diabet Med 1991;8:217–222.

    Google Scholar 

  50. Frier BM. Hypoglycemia and cognitive function in diabetes. Int J Clin Pract 2001;(Suppl)123:30–37.

    Google Scholar 

  51. Strachan MW, Dreary IJ, Ewing FM, Frier BM. Recovery of cognitive function and mood after severe hypoglycemia in adults with insulin-treated diabetes. Diabetes Care 2000;23:305–312.

    Google Scholar 

  52. Cox DJ, Gonder-Frederick LA, Kovatchev BP, Julian DM, Clarke WL. Progressive hypoglycemia's impact on driving simulation performance: Occurrence, awareness and correction. Diabetes Care 2000;23:163–170.

    Google Scholar 

  53. Austin EJ, Dreary IJ. Effects of repeated hypoglycemia on cognitive function: A pyschometrically validated reanalysis of the diabetes control and complications trial data. Diabetes Care 1999;22:1273–1277.

    Google Scholar 

  54. Dreary IJ, Crawford JR, Hepburn DA. Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes 1993;42:341–344.

    Google Scholar 

  55. Tattersall RB, Gill GV. Unexplained deaths of type 1 diabetic patients. Diabet Med 1991;8:49–58.

    Google Scholar 

  56. Jones TW, Porter P, Sherwin RS, Davis EA, O'Leary P, Frazier F, Byrne G, Stick S, Tamborlane WV. N Engl J Med 1998;338:1657–1662.

    Google Scholar 

  57. Sovik O, Thordarson H. Dead-in-bed syndrome in young diabetic patients. Diabetes Care 1999;22(Suppl 2):B40–B42.

    Google Scholar 

  58. Abraira C, Colwell JA, Nutall FQ, Sawin, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS. Veterans affairs cooperative study on glycemic control and complications in type 2 diabetes. Diabetes Care 1995;18:1113–1123.

    Google Scholar 

  59. Pramming S, Thorsteinsson B, Bendtson I, Ronn B, Binder C. Symptomatic hypoglycemia in 411 type 1 diabetic patients. Diabetic Med 1991;8:217–222.

    Google Scholar 

  60. MacLeod KM, Hepburn DA, Frier BM. Frequency and morbidity of severe hypoglycemia in insulin-treated diabetic patients. Diabetic Med 1993;10:238–245.

    Google Scholar 

  61. Schichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 2000;23(Suppl 2):B21–B29.

    Google Scholar 

  62. Johnson ES, Koepsell TD, Reiber G, Stergachis A, Platt R. Increasing incidence of serious hypoglycemia in insulin users. J Clin Epidemiol 2002;55:253–259.

    Google Scholar 

  63. Miller CD, Lawrence SP, Ziemer DC, Gallina DL, Cook CD, El-Kebbi IM. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med 2001;161:1653–1659.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology and Metabolism, Department of Internal Medicine, University of New Mexico School of Medicine, USA

    Mary F. Carroll, Mark R. Burge & David S. Schade

Authors
  1. Mary F. Carroll
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark R. Burge
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David S. Schade
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carroll, M.F., Burge, M.R. & Schade, D.S. Severe Hypoglycemia in Adults. Rev Endocr Metab Disord 4, 149–157 (2003). https://doi.org/10.1023/A:1022990003161

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022990003161

Search

Navigation